Equities

Sino Medical Sciences Technology Inc

688108:SHH

Sino Medical Sciences Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (CNY)10.26
  • Today's Change-0.44 / -4.11%
  • Shares traded12.72m
  • 1 Year change-18.57%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sino Medical Sciences Technology Inc is a China-based company mainly engaged in the research, development, production and sales of high-end interventional medical devices. The Company's product pipeline covers the field of interventional therapy such as cardiovascular, cerebrovascular, and structural heart disease. The Company's main products include coronary drug stent system and balloon dilatation catheters. The Company conducts its businesses within the domestic market and overseas markets, and it has subsidiaries in Beijing, China, Hong Kong, China, the United States, Japan, the Netherlands, and France.

  • Revenue in CNY (TTM)417.13m
  • Net income in CNY-4.63m
  • Incorporated2007
  • Employees652.00
  • Location
    Sino Medical Sciences Technology Inc3F, Area A,TEDA Biomedical R&D Mansion, No. 5 FourTIANJIN 300457ChinaCHN
  • Phone+86 1 082163261
  • Fax+86 1 082162787
  • Websitehttp://www.sinomed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Well Lead Medical Co Ltd1.47bn215.29m3.90bn2.62k17.972.12--2.650.74020.74025.066.270.57624.687.77561,039.908.818.2510.5610.1744.3743.4515.2913.041.49239.620.231851.111.7913.2215.5624.1035.3945.41
SWS Hemodialysis Care Co Ltd532.45m74.82m3.96bn881.0052.912.34--7.440.2330.2331.665.270.27591.864.66604,373.603.72--4.02--46.37--13.47--10.93--0.016--80.65--228.34------
Goodwill E-Health Info Co Ltd633.21m-16.79m4.13bn2.05k--2.31--6.52-0.1239-0.12394.5912.990.24720.54430.7415308,883.90-1.281.28-1.781.9549.2150.60-5.183.481.75-2.750.14730.00-3.0422.09-37.53--66.10--
Sino Medical Sciences Technology Inc417.13m-4.63m4.24bn652.00--4.95--10.17-0.0112-0.01121.012.070.34981.4533.50639,765.50-0.3445-4.21-0.411-4.7160.2270.96-0.985-15.761.61--0.1327--77.99-2.0475.59---7.30--
Getein Biotech Inc1.25bn252.99m4.37bn2.14k17.261.68--3.500.49880.49882.465.120.32411.622.91584,007.906.7313.259.8618.4567.6465.5720.7628.131.69--0.20529.88-24.8514.81-43.922.3118.446.00
Qingdao NovelBeam Technology Co Ltd413.02m124.91m4.40bn797.0035.173.43--10.661.041.043.4410.630.29620.86634.68518,221.708.8114.679.3716.6363.8562.3229.7334.159.12--0.026233.55-1.3118.58-20.1921.7110.45--
Jiangsu Bioperfectus Technologies Co Ltd394.84m-170.68m4.59bn684.00--1.40--11.62-2.91-2.916.7458.000.0970.97472.52577,244.10-4.1925.41-4.7431.2665.7063.37-43.2332.864.96--0.090330.54-92.7211.81-120.45--2.43--
Data as of Nov 15 2024. Currency figures normalised to Sino Medical Sciences Technology Inc's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

15.88%Per cent of shares held by top holders
HolderShares% Held
Guotai Asset Management Co., Ltd.as of 30 Jun 202437.76m13.14%
Baoying Fund Management Co., Ltd.as of 30 Jun 20241.58m0.55%
Ping An Fund Management Co., Ltd.as of 30 Jun 20241.45m0.51%
China Southern Asset Management Co., Ltd.as of 30 Jun 20241.03m0.36%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024876.20k0.31%
Wanjia Asset Management Co., Ltd.as of 30 Jun 2024876.03k0.31%
Essence Fund Co., Ltd.as of 30 Jun 2024696.66k0.24%
ABC-CA Fund Management Co., Ltd.as of 30 Jun 2024515.01k0.18%
JX Asset Management Co.,Ltdas of 30 Jun 2024469.00k0.16%
UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2024373.45k0.13%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.